Viewing Study NCT00511992

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:25 PM
Ignite Modification Date: 2026-02-20 @ 6:42 PM
Study NCT ID: NCT00511992
Status: COMPLETED
Last Update Posted: 2017-07-02
First Post: 2007-08-03
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer
Sponsor: University of Oklahoma
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Ovarian Carcinoma View
None Primary Peritoneal Carcinoma View
None Ovarian Carcinosarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ovarian Cancer View
None Gynecologic Cancer View
None Ovarian Carcinoma View
None Peritoneal Carcinoma View
None IP chemotherapy View
None Intraperitoneal View
None Avastin View
None Bevacizumab View